Is Centene Corp (CNC) overvalued? · P/E 8.4, rev $163.07B
Centene Corp (CNC) is a healthcare plans company listed on US.
This page asks whether Centene Corp (CNC) looks expensive on cached numbers — not a short thesis.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CNC 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CNC stock page for the full model, not this heading.
Not investment advice.